Overview
Scilife builds an electronic quality management system (eQMS) for the life sciences sector. The platform covers document management, quality events, change control, risk management, quality KPIs, training, CAPA, audits, equipment management, design and development, and controlled printing and reconciliation. It serves pharmaceutical, biotech, medical device, healthcare logistics and medicinal cannabis companies. The first customer was onboarded in 2019 and the company rebranded as Scilife in 2022. A US subsidiary followed in 2023. The EMEA office is at Kantersteen 47 in Brussels; the US office is in New York. On June 6, 2024 Scilife announced a strategic growth investment from Five Elms Capital. The amount was not disclosed; the transaction involved a transfer of shares to Five Elms Capital, with existing shareholders partially rolling over. On September 2, 2024 Sebastien Sepierre, previously Managing Director at Fourth and earlier at IBM, was appointed CEO. Heitbrink remains on the Board of Directors as co-founder. At the time of the CEO change Scilife had more than 200 customers and more than 70 employees. The company now reports more than 90 employees, more than 240 customers and more than 22,500 users, and is ISO 9001 certified. Named customers include Novartis, Biocartis, Yusen Logistics, Polpharma, Pendulum, Qualiphar, Coriolis Pharma, Idevax and Amnovis.
Funding history
- 2024 Growth equity: Undisclosed strategic growth investment by Five Elms Capital, structured as a share transfer with shareholders partially rolling over
Stated facts & numbers
- Founded: 2017
- Headquarters: Brussels (EMEA), New York (US)
- Founder: Filip Heitbrink (co-founder, board member, former CEO)
- CEO: Sebastien Sepierre (since September 2024)
- Employees: 90+
- Customers: 240+, including Novartis, Biocartis, Yusen Logistics, Polpharma, Pendulum
- Investor: Five Elms Capital (2024)
- Certification: ISO 9001
In the news
- A day in the life of a QA. What does it look like? Well you may as well throw the dice and let it tell you. Of course, everybody starts the week with a plan. “I want to tackle these overdue trainings and take a look at the vial labeling process which has generated more deviations than I’d like over the last 6 months.” You rock up to work and then are met at the door by a couple of critical deviations and if you’re extra lucky a marathon CAPA review session in light of the upcoming audit. Then you make the mistake of blinking and
- What determines whether AI strengthens your quality culture, or it just becomes another tool? It isn't technology alone. It’s how people lead, collaborate, and make decisions around it. 🎤 At the Scilife Quality Summit 2026, Natalia Vtyurina, PhD, sMBA, Founder and Chair of the ISPE Netherlands Quality Community of Practice, will explore this in her session, Building quality culture in the age of AI: Leadership, collaboration and responsible decision-making. Drawing on her expertise in advanced therapies, quality operations, and
- Just one month to go until the Scilife Quality Summit 2026! AI is changing how quality works, but not who remains accountable. Join leading voices from across life sciences to explore what compliant, responsible AI adoption looks like in practice, from governance and validation to CAPAs, quality culture, and strategic decision-making. 👉 Secure your spot now: https://lnkd.in/e_wjgXQ4 Here’s a sneak peek at the sessions you’ll be able to join: ⏰ 12:00 CEST / 6:00 EDT AI governance and validation: The orchestrator approach with
- A regulatory update lands in someone’s inbox. It gets forwarded to Quality. A meeting is scheduled. Everyone agrees something needs to happen. And then… nothing does. Regulatory intelligence isn’t just about knowing that something changed. It needs to answer three questions: What changed? What does it mean for the organization? What needs to happen next? Automation and AI can make that process significantly more efficient. Standard automation can monitor sources, classify updates, filter irrelevant information and trigger
- The Scilife team is heading to Potsdam, Germany, for the German Quality Management Association e.V. 2026! Partner Manager Christopher Hayden and BDR Nezka Zupan-Dusak, PhD will be attending the event to get a clearer insight into the issues on the quality agenda within the German market specifically. With sessions addressing GMP, validation and specific ICH regulations, there will be lots of specific insights to take back with the. Come meet the team, they'll be ready to chat about all things quality management! Will you also
- We asked Mythbusters to do an episode on QA but they didn’t get back to us so you’re stuck with us I’m afraid. Welcome to✨ QA fact vs fiction ✨ We’ve listed some common QA myths and what the reality actually is. 😬 An audit trail is just a log of who changed what. 😬 SOPs should be written by QA alone. 😬 Compliance is the finish line. 😬 Every deviation needs a full CAPA. 😬 A validated system never needs revalidation. Okay you can take your hands off your ears now. Those were just the misconceptions, don't worry. We know for
- Quality under Scrutiny, indeed. 🔎 This week, Scilife + RiverArk Limited brought Quality leaders together in Oxford for an open, straight-talking conversation around AI, inspection readiness, and what it really means to operate across GMP, GCP, and wider GxP environments today. No polished theory. No “AI will change everything” slides. Just real Quality people, real questions, practical challenges, and plenty of lessons from the field. 👀 Reflecting on the conversations from the session, Christopher Hayden, Partner Manager
- When does AI stop being a technology discussion and become a quality discussion? The moment it influences a GxP process, patient safety, data integrity, or a decision your organization may need to defend. Then comes another important question: Where can AI create real value for QA, and where are we expecting too much from it? 🎤 At the Scilife Quality Summit 2026, Marta Rodríguez Vélez, Head of Corporate Quality at LETI Pharma, will explore these questions in her session, From gatekeeper to strategic partner. Drawing on more than
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.










